Christian Mirkes1,2, Gunamony Shajan3, Grzegorz Chadzynski4,3, Kai Buckenmaier3, Benjamin Bender5, Klaus Scheffler4,3. 1. Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany. christian.mirkes@tuebingen.mpg.de. 2. High-Field MR Center, Max Planck Institute for Biological Cybernetics, Spemannstr. 41, 72076, Tübingen, Germany. christian.mirkes@tuebingen.mpg.de. 3. High-Field MR Center, Max Planck Institute for Biological Cybernetics, Spemannstr. 41, 72076, Tübingen, Germany. 4. Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany. 5. Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.
Abstract
OBJECTIVE: Investigation of the feasibility and performance of phosphorus ((31)P) magnetic resonance spectroscopic imaging (MRSI) at 9.4 T with a three-layered phosphorus/proton coil in human normal brain tissue and tumor. MATERIALS AND METHODS: A multi-channel (31)P coil was designed to enable MRSI of the entire human brain. The performance of the coil was evaluated by means of electromagnetic field simulations and actual measurements. A 3D chemical shift imaging approach with a variable repetition time and flip angle was used to increase the achievable signal-to-noise ratio of the acquired (31)P spectra. The impact of the resulting k-space modulation was investigated by simulations. Three tumor patients and three healthy volunteers were scanned and differences between spectra from healthy and cancerous tissue were evaluated qualitatively. RESULTS: The high sensitivity provided by the 27-channel (31)P coil allowed acquiring CSI data in 22 min with a nominal voxel size of 15 × 15 × 15 mm(3). Shimming and anatomical localization could be performed with the integrated four-channel proton dipole array. The amplitudes of the phosphodiesters and phosphoethanolamine appeared reduced in tumorous tissue for all three patients. A neutral or slightly alkaline pH was measured within the brain lesions. CONCLUSION: These initial results demonstrate that (31)P 3D CSI is feasible at 9.4 T and could be performed successfully in healthy subjects and tumor patients in under 30 min.
OBJECTIVE: Investigation of the feasibility and performance of phosphorus ((31)P) magnetic resonance spectroscopic imaging (MRSI) at 9.4 T with a three-layered phosphorus/proton coil in human normal brain tissue and tumor. MATERIALS AND METHODS: A multi-channel (31)P coil was designed to enable MRSI of the entire human brain. The performance of the coil was evaluated by means of electromagnetic field simulations and actual measurements. A 3D chemical shift imaging approach with a variable repetition time and flip angle was used to increase the achievable signal-to-noise ratio of the acquired (31)P spectra. The impact of the resulting k-space modulation was investigated by simulations. Three tumorpatients and three healthy volunteers were scanned and differences between spectra from healthy and cancerous tissue were evaluated qualitatively. RESULTS: The high sensitivity provided by the 27-channel (31)P coil allowed acquiring CSI data in 22 min with a nominal voxel size of 15 × 15 × 15 mm(3). Shimming and anatomical localization could be performed with the integrated four-channel proton dipole array. The amplitudes of the phosphodiesters and phosphoethanolamine appeared reduced in tumorous tissue for all three patients. A neutral or slightly alkaline pH was measured within the brain lesions. CONCLUSION: These initial results demonstrate that (31)P 3D CSI is feasible at 9.4 T and could be performed successfully in healthy subjects and tumorpatients in under 30 min.
Entities:
Keywords:
9.4 T; CSI; Phosphorus; Spectroscopy; Tumor; Ultra-high field
Authors: Marek Chmelik; Michal Považan; Martin Krššák; Stephan Gruber; Martin Tkačov; Siegfried Trattnig; Wolfgang Bogner Journal: NMR Biomed Date: 2014-02-24 Impact factor: 4.044
Authors: Miriam W Lagemaat; Eline K Vos; Marnix C Maas; Andreas K Bitz; Stephan Orzada; Mark J van Uden; Thiele Kobus; Arend Heerschap; Tom W J Scheenen Journal: Invest Radiol Date: 2014-05 Impact factor: 6.016
Authors: Steven P Allen; Glen R Morrell; Brock Peterson; Danny Park; Garry E Gold; Joshua D Kaggie; Neal K Bangerter Journal: Magn Reson Med Date: 2010-11-30 Impact factor: 4.668
Authors: Philip M Robson; Aaron K Grant; Ananth J Madhuranthakam; Riccardo Lattanzi; Daniel K Sodickson; Charles A McKenzie Journal: Magn Reson Med Date: 2008-10 Impact factor: 4.668
Authors: B Barbiroli; P Montagna; P Martinelli; R Lodi; S Iotti; P Cortelli; R Funicello; P Zaniol Journal: J Cereb Blood Flow Metab Date: 1993-05 Impact factor: 6.200
Authors: Bart L van de Bank; Stephan Orzada; Frits Smits; Miriam W Lagemaat; Christopher T Rodgers; Andreas K Bitz; Tom W J Scheenen Journal: NMR Biomed Date: 2015-10-07 Impact factor: 4.044
Authors: Siegfried Trattnig; Elisabeth Springer; Wolfgang Bogner; Gilbert Hangel; Bernhard Strasser; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson Journal: Neuroimage Date: 2016-11-13 Impact factor: 6.556
Authors: Chang-Hoon Choi; Carina Stegmayr; Aliaksandra Shymanskaya; Wieland A Worthoff; Nuno A da Silva; Jörg Felder; Karl-Josef Langen; N Jon Shah Journal: EJNMMI Phys Date: 2020-07-29
Authors: Andreas Korzowski; Nina Weckesser; Vanessa L Franke; Johannes Breitling; Steffen Goerke; Heinz-Peter Schlemmer; Mark E Ladd; Peter Bachert; Daniel Paech Journal: Front Neurol Date: 2021-12-23 Impact factor: 4.003
Authors: Loreen Ruhm; Nikolai Avdievich; Theresia Ziegs; Armin M Nagel; Henk M De Feyter; Robin A de Graaf; Anke Henning Journal: Neuroimage Date: 2021-10-09 Impact factor: 6.556